Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.
Panagora Group's Monitoring, Evaluation, Research, and Learning (MERL) Activity supports USAID/South Africa’s bilateral Health Office by working collaboratively with health office staff to achieve their overall goals by creatively finding innovative solutions, supplementing and complementing their existing staff capacity, and as appropriate enhancing capacity in performance management; evaluation and research; and systematic collaboration, continuous learning, and adaptive management. We are looking for creative, dynamic, results focused and experienced professionals to be part of a pool of consultants that we can call on to support USAID/South Africa’s bilateral Health Office with a variety of needs in the area of HIV and AIDS.
We assessed the relationship between distance to clinic and progression through the HIV care cascade. We have two key findings. First, distance matters but only for women. Second, for women, distance affected linkage to care, but was not associated with later transitions in the care cascade.
Treatment success rates of rifampicin resistant (RR)/multi-drug resistant (MDR) tuberculosis (TB) in South Africa range from 43–48%, falling short of the World Health Organization’s target of ≥75%. We present rates and assess predictors of attrition by 12 months on treatment.
Depression is a leading cause of disability and may be associated with decreased adherence to ART. We sought to describe the prevalence of depressive symptoms and outcomes one year after screening among patients receiving ART at a large HIV Clinic in Johannesburg, South Africa.
This report presents the preliminary findings from an ongoing project undertaken by 4Children that seeks to identify key opportunities to incorporate violence prevention and response interventions within priority PEPFAR Program Areas at clinical and community levels.
The objective of this toolkit is to provide guidance on the disclosure process of an HIV status for pediatric and adolescent populations. This document contains tools for use in clinical practice to build the capacity of health care workers, caregivers, and pediatric and adolescent patients themselves in assisting with and delivering successful and informed disclosure.